Bulgaria allocates further 19.9 million euro for COVID-19 treatment

Bulgaria allocates further 19.9 million euro for COVID-19 treatment

Bulgaria's caretaker government said that it allocated an additional 38.9 million levs ($23.0 million/19.9 million euro) to the budget of the health ministry to finance a new contract for the purchase of Veklury (INN Remdesivir), a medicine used for the treatment of Covid-19, and pay for already completed deliveries of the same medicine.

The new contract envisages the supply of at least 30,000 doses of the Veklury medicine within a period of six months, the caretaker government said in a statement on Wednesday.

Remdesivir is manufactured by US-based company Gilead Sciences and sells under the Veklury brand name. Veklury was the first medicine approved by the European Commission for treatment of COVID-19.

According to data published by the health ministry on Thursday, there are 500,112 confirmed cases of COVID-19 in Bulgaria, of which 43,520 are still active.

Previous Next
Test Caption
Test Description goes like this
Cookies Preferences
Choose Type of Cookies You Accept Using

These cookies are required for the website to run and cannot be switched off. Such cookie are only set in response to actions made by you such as language, currency, login session, privacy preferences. You can set your browser to block these cookies but our site may not work then.

These cookies allow us to measure visitors traffic and see traffic sources by collecting information in data sets. They also help us understand which products and actions are more popular than others.

These cookies are usually set by our marketing and advertising partners. They may be used by them to build a profile of your interest and later show you relevant ads. If you do not allow these cookies you will not experience targeted ads for your interests.